Meditation for Lung Cancer
Trial Summary
The trial information does not specify whether you need to stop taking your current medications. It seems likely that you can continue your existing treatments, as the trial is focused on meditation and does not mention medication changes.
Research suggests that mindfulness and self-compassion, which are part of couple-based meditation, may help reduce distress and improve communication in couples facing lung cancer. These skills could positively impact how couples cope with the challenges of cancer.
12345Research on mindfulness and meditation for lung cancer patients and their partners suggests these practices are generally safe and may help reduce psychological distress. No specific safety concerns have been reported in the studies reviewed.
24567Couple-Based Meditation is unique because it focuses on mindfulness and self-compassion skills for both lung cancer patients and their partners, aiming to reduce psychological distress and improve communication within the couple, rather than directly targeting the cancer itself.
23456Eligibility Criteria
This trial is for patients over 18 with stage IV Non-Small Cell Lung Cancer (NSCLC) who are being treated at MD Anderson Cancer Center and have an ECOG status of ≤2. They must live with a romantic partner for at least 6 months. Both patient and partner should speak English, be able to consent, and not participate in regular psychotherapy or cancer support groups.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Phase 1: Couple-Based Mindfulness Disclosure Group
Couples participate in 2 guided meditation sessions involving deep breathing and visualization exercises, followed by feedback and a written review.
Phase 2: Couple-Based Mindfulness Disclosure Group
Participants complete 12 questionnaires and participate in 4 guided meditation sessions with a trained instructor, including daily meditation practice at home.
Phase 3: Cancer-Related Discussion Program Group
Participants and partners engage in a discussion program with a trained interventionist, focusing on coping with cancer.
Follow-up
Participants are monitored for safety and effectiveness after treatment, with questionnaires completed 3 months later.